Molecular Devices launches new multi-mode microplate reader for academia and biotech laboratories

The budget-friendly SpectraMax® Mini Multi-Mode Microplate Reader maximizes productivity without compromising sensitivity or performance  San Jose, Calif., April 14, 2022 – Molecular Devices, LLC., a leading provider of high-performance life science solutions and a company of Danaher Corporation (NYSE:DHR), has today launched its SpectraMax® Mini Multi-Mode Microplate Reader, a compact and economical solution designed to save researchers benchtop... Read more

Scitara announces collaboration with PerkinElmer Informatics to create new model of the modern lab

Marlborough, MA – April 14, 2022 – Market leading innovator in laboratory digital transformation, Scitara, has announced a collaboration with scientific analytical technology leader, PerkinElmer. The move will support the integration of the PerkinElmer® Signals Research Suite™ informatics platform, which provides seamless, end-to-end scientific data and workflow management, with laboratory instruments, applications and resources via the... Read more

Exploring Malaria Parasite Entry into Red Blood Cells

Dr. Sonja Frölich caught our attention with her tweet demonstrating her use of ZEISS Airyscan super-resolution technology to study an organelle which the malaria parasite uses to invade red blood cells by analyzing thousands of samples in a non-biased, semi-automated fashion. Dr. Sonja Frölich is a postdoctoral researcher at the Malaria Biology (Wilson) Laboratory located... Read more

Molecular Devices continues investment in Organoid Innovation Center adding cell engineering capabilities to automated 3D cell culture platform

Next-gen 3D biology lab programs stem cells that differentiate and self-organize into organoid models with higher reproducibility and consistency for screening San Jose, Calif., April 12, 2022 – Molecular Devices, LLC., a leading provider of high-performance life science solutions, this month celebrates the one-year anniversary of its automated 3D imaging workcell, the Organoid Innovation Center, located at... Read more

Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock

Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock WASHINGTON, April 12, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 4.75% Series A Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s Common Stock on April 15, 2022 (the “Conversion Date”). The conversion rate... Read more

Xylem Invests $20M in Venture Capital Funds to Support Early-Stage Water Technology Development

Xylem Announces Investments in Technology Development Funds Burnt Island Ventures and The Westly Group RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 12, 2022– Global water technology company, Xylem (NYSE:XYL), has announced Limited Partner (LP) investments in venture capital funds Burnt Island Ventures and The Westly Group’s Funds III and IV, supporting the development of innovative water and industrial... Read more